Changes in symptoms of insomnia and excessive daytime sleepiness during the COVID-19 pandemic by age. by Hea Ree Park (10769827)

Subjects:

Effect of Bcl-xL on proteins involved in the apoptotic pathway of MDCK cells. by Jiahao Zheng (807470)

Subjects:

Effect of Bcl-xl on the tumorigenicity of MDCK cells in nude mice. by Jiahao Zheng (807470)

Subjects:

Changes in sleep patterns before versus during the COVID-19 pandemic by age. by Hea Ree Park (10769827)

Subjects:

Sociodemographic characteristics. by Hea Ree Park (10769827)

Subjects:

Changes in sleep habits and sleep-related symptoms. by Hea Ree Park (10769827)

Subjects:

Analysis and comparison of transcriptome data between WT and BY-02 cells. by Jiahao Zheng (807470)

Subjects:

Regression analysis of sleep habits and sleep-related symptoms associated with pandemic status. by Hea Ree Park (10769827)

Subjects:

The targeting strategies, qRT-PCR, and western bolt to verify BY-02 cells. by Jiahao Zheng (807470)

Subjects:

Study flow chart. by Hea Ree Park (10769827)

Subjects:

Differences in growth, metabolism and migration of BY-02 cells compared with WT cells. by Jiahao Zheng (807470)

Subjects:

Transcriptome analysis. by Jiahao Zheng (807470)

Subjects:

Proportion that sought care at a hospital or clinic in LMICs by observation characteristics. by Kirsten E. Wiens (9902027)

Factors in the past medical history for cases and control. by Faith Muthoki Mwanzui (21353873)

Subjects:

Prevalence of major symptom new clusters/symptoms and associated severity ratings according to validated questionnaires by case-control status at clinical examination in phase 2. by Raphael S. Peter (12044198)

Results of PCV2 cases tested by PCR over time (2002–2023). by Guilherme Cezar (17816844)

Subjects:

Results of PCV3 cases tested by PCR over time (2017–2023). by Guilherme Cezar (17816844)

Subjects:

Table 1_Prevalence and clinical significance of the genotypic carriage among ESBL phenotype-negative Escherichia coli and Klebsiella pneumoniae clinical isolates in bacteremia: a s... by Chee Lan Lau (18433467)

“…The patient characteristics were similar among 98 ESBL phenotype-negative cases, except that the non-bla_CTX-M carrier group had significantly more renal impairment (0/37 vs 7/61, p = 0.043) and gastrointestinal sources of bacteremia (9/37 vs 27/61, p = 0.047). …”

Epidemiological distribution of the analyzed 176 HGA and 272 HME cases according to age, sex, and immune status using US data. by Christian Kositz (3404624)

AUCs of models with OFI cases (Non-DHF vs. DHF classification) and without OFI cases (DF vs. DHF classification) trained and tested on the combined multi-site dataset. by Myat Su Yin (7053629)